MDM2 inhibitors in sarcomas: results and next steps
Ilaria Tortorelli(Istituto Oncologico Veneto), Robin L. Jones(Institute of Cancer Research), Andrea Napolitano(National Health Service), Paul H. Huang(Institute of Cancer Research), Yuhong Zhou(Sun Yat-sen University)
Cited by 2
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|751
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|641